Eris Lifesciences shares rise in debut after $264 million IPO

Indian drugmaker Eris Lifesciences Ltd’s (ERIS.NS) shares rose as much as 4.2 percent on their trading debut on Thursday, after its initial public offering raised 17 billion rupees ($ 263.8 million).

The shares were up 1.2 percent at 610.45 rupees by 0434 GMT on the National Stock Exchange, compared with their IPO price of 603 rupees.